Literature DB >> 14718436

Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions.

José Manuel Porcel1, Manuel Vives, Aureli Esquerda.   

Abstract

STUDY
OBJECTIVES: We sought to determine whether pleural fluid tumor necrosis factor (TNF)-alpha is a more accurate parameter to identify nonpurulent complicated parapneumonic effusion (CPPE) than the classical chemistries, namely pH, glucose, or lactate dehydrogenase (LDH).
METHODS: We studied 80 consecutive patients with parapneumonic effusions (35 with uncomplicated parapneumonic effusion [UPPE], 23 with nonpurulent CPPE, and 22 with empyema). Concentrations of standard biochemical parameters together with TNF-alpha were measured in pleural fluid, the latter by using an immunoenzymometric assay.
RESULTS: Pleural TNF-alpha was significantly higher in CPPE (133.0 pg/mL) and empyema (142.2 pg/mL) than in UPPE (39.1 pg/mL). A cut-off value of 80 pg/mL for pleural TNF-alpha resulted in a sensitivity, specificity, and area under receiver operating characteristic curve (AUC) of 78%, 89%, and 0.87, respectively, for the diagnosis of nonpurulent CPPE. A multivariate analysis selected both pleural TNF-alpha > or = 80 pg/mL and LDH > or = 1,000 U/L (sensitivity, 74%; AUC = 0.86), but excluded pleural glucose < or = 60 mg/dL (sensitivity, 39%; AUC = 0.82) and pH < or = 7.20 (sensitivity, 41%; AUC = 0.78), for identifying the need for drainage. The combined sensitivity of pleural fluid TNF-alpha and LDH was found to be 91%.
CONCLUSIONS: Pleural TNF-alpha may contribute to the identification of patients with nonpurulent CPPE with at least the same diagnostic accuracy, if not better, than the use of pH, glucose, or LDH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718436     DOI: 10.1378/chest.125.1.160

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  The role of pleural fluid-serum gradient of tumor necrosis factor-alpha concentration in discrimination between complicated and uncomplicated parapneumonic effusion.

Authors:  M Odeh; B Makhoul; E Sabo; I Srugo; A Oliven
Journal:  Lung       Date:  2005 Jan-Feb       Impact factor: 2.584

2.  Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.

Authors:  S C Chen; W Chen; W H Hsu; Y H Yu; C M Shih
Journal:  Lung       Date:  2006 May-Jun       Impact factor: 2.584

3.  Serum C-reactive protein as an adjunct for identifying complicated parapneumonic effusions.

Authors:  Silvia Bielsa; Horacio Valencia; Agustín Ruiz-González; Aureli Esquerda; José M Porcel
Journal:  Lung       Date:  2014-06-10       Impact factor: 2.584

4.  Tumor necrosis factor alpha and high sensitivity C-reactive protein in diagnosis of exudative pleural effusion.

Authors:  Fariba Rezaeetalab; Seyed Mohhamad Reza Parizadeh; Habibollah Esmaeely; Hadi Akbari; Farzaneh Akbari; Soheila Saberi
Journal:  J Res Med Sci       Date:  2011-11       Impact factor: 1.852

5.  Serum amyloid alpha in parapneumonic effusions.

Authors:  Vagelis Boultadakis; Vasilis Skouras; Demosthenes Makris; Aggeliki Damianaki; Dimitrios J Nikoulis; Theodoros Kiropoulos; Smaragda Oikonomidi; Irene Tsilioni; Konstantinos Gourgoulianis
Journal:  Mediators Inflamm       Date:  2011-08-25       Impact factor: 4.711

6.  Proteome profiling reveals novel biomarkers to identify complicated parapneumonic effusions.

Authors:  Kuo-An Wu; Chih-Ching Wu; Chi-De Chen; Chi-Ming Chu; Li-Jane Shih; Yu-Ching Liu; Chih-Liang Wang; Hsi-Hsien Lin; Chia-Yu Yang
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

7.  Factors predictive of the failure of medical treatment in patients with pleural infection.

Authors:  Sung-Kyoung Kim; Chul Ung Kang; So Hyang Song; Deog Gon Cho; Kyu Do Cho; Chi Hong Kim
Journal:  Korean J Intern Med       Date:  2014-08-28       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.